• OPEN AN ACCOUNT
Indian Indices
Nifty
24,625.05 198.20
(0.81%)
Sensex
80,364.49 554.84
( 0.70%)
Bank Nifty
54,002.45 346.80
( 0.65%)
Nifty IT
35,740.65 559.40
( 1.59%)
Global Indices
Nasdaq
45,566.70 -91.21
(-0.20%)
Dow Jones
6,481.27 -41.59
(-0.64%)
Hang Seng
42,138.74 -579.73
(-1.36%)
Nikkei 225
9,196.34 9.00
(0.10%)
Forex
USD-INR
87.60 0.00
(0.00%)
EUR-INR
102.16 0.00
(0.00%)
GBP-INR
118.33 0.00
(0.00%)
JPY-INR
0.60 0.00
(0.00%)

EQUITY - MARKET SCREENER

Vilin Bio Med Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
78871
INE0L4V01013
16.5329749
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
VILINBIO
168.13
37.53
EPS(TTM)
Face Value()
Div & Yield %
0.16
10
0
 

sterling powergensys ltd
Davangere Sugar Company standalone net profit rises 38.30% in the June 2025 quarter
Aug 15,2025
Net profit of Davangere Sugar Company rose 38.30% to Rs 1.30 crore in the quarter ended June 2025 as against Rs 0.94 crore during the previous quarter ended June 2024. Sales declined 47.18% to Rs 24.07 crore in the quarter ended June 2025 as against Rs 45.57 crore during the previous quarter ended June 2024.

ParticularsQuarter Ended
Jun. 2025Jun. 2024% Var.
Sales24.0745.57 -47
OPM %47.3220.76 -
PBDT4.904.34 13
PBT1.721.36 26
NP1.300.94 38